Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. [electronic resource]
Producer: 20070830Description: 33-44 p. digitalISSN:- 0003-3022
- Adrenergic beta-Antagonists -- therapeutic use
- Anesthesia, Spinal
- Bisoprolol -- therapeutic use
- Cardiomyopathy, Dilated -- mortality
- Cardiovascular Diseases -- mortality
- Coronary Disease -- mortality
- Double-Blind Method
- Electrocardiography, Ambulatory
- Follow-Up Studies
- Genotype
- Humans
- Intraoperative Complications -- mortality
- Myocardial Infarction -- mortality
- Postoperative Complications -- mortality
- Proportional Hazards Models
- Receptors, Adrenergic -- genetics
- Respiratory Function Tests
- Risk
- Switzerland
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.